日本老年人流感疫苗有效性的持续时间:基于大规模人群登记数据的回顾性队列研究
该研究利用日本关东地区某市2014年4月1日至2020年3月31日的医保理赔与接种记录链接数据库,纳入83,146名65岁及以上老年人,采用时依分段Cox比例风险模型分析不同年龄组流感疫苗有效性的持续时间;结果显示接种者流感发病风险降低(HR 0.47,95%CI 0.43-0.51,P<0.001),但住院风险无显著差异(HR 0.79,95%CI 0.53-1.18,P=0.249),保护效果随时间逐渐减弱。
要点
- 接种流感疫苗者流感发病风险低于未接种者(HR 0.47,95%CI 0.43-0.51,P<0.001)。
- 接种者流感相关住院风险与未接种者无显著差异(HR 0.79,95%CI 0.53-1.18,P=0.249)。
- 65-69岁和80岁及以上人群接种后保护效果维持4或5个月,70-79岁人群维持5个月。
核心结论
- 研究显示日本老年人接种流感疫苗对预防流感发病具有中等有效性,疫苗有效性呈逐渐减弱趋势。
- 作者认为即使接种过疫苗,尤其距接种已超过4或5个月的老年人,临床医生仍应怀疑流感感染。
研究设计与样本
- 回顾性队列研究,使用日本关东地区某市医保行政理赔数据与接种记录的链接数据库。
- 研究对象为基线时65岁及以上、随访期为2014年4月1日至2020年3月31日的个体。
- 分析人群83,146人,其中7,401人(8.9%)发生流感,270人(0.32%)因流感相关住院。
- 第一季接种者47,338人,未接种者35,808人;接种者平均年龄75.8岁,未接种者平均年龄74.1岁。
- 采用时依分段Cox比例风险模型,调整时依疫苗状态、既往季节接种及基线协变量(年龄、性别、癌症、糖尿病、慢性阻塞性肺疾病、哮喘、慢性肾脏病、心血管疾病)。
主要发现
- 接种者流感发病风险低于未接种者(HR 0.47,95%CI 0.43-0.51,P<0.001)。
- 接种者流感相关住院风险与未接种者无显著差异(HR 0.79,95%CI 0.53-1.18,P=0.249)。
- 65-69岁和80岁及以上人群接种后保护效果维持4或5个月,70-79岁人群维持5个月。
临床怎么用
- 作者认为即使接种过疫苗,尤其距接种已超过4或5个月的老年人,临床医生仍应怀疑流感感染。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The immune response to influenza vaccination in the elderly is likely to be lower than that in young adults. Clinical protection may not persist year-round in the elderly. However, the effectiveness of influenza vaccine in the elderly has not been adequately studied, especially in terms of the duration of effectiveness. METHODS: We used a linked database of healthcare administrative claims data and vaccination records maintained by the municipality of a city in Kanto region of Japan. We studied individuals who were aged 65 years or older at baseline and were followed up between April 1, 2014 to March 31, 2020. The duration of influenza vaccine effectiveness by age category was analyzed using a time-dependent piecewise Cox proportional hazard model with time-dependent vaccine status, prior season vaccination and covariates confirmed in the baseline period (age, sex, cancer, diabetes, chronic obstructive pulmonary diseases, asthma, chronic kidney diseases, and cardiovascular diseases). RESULTS: We identified an analysis population of 83,146 individuals, of which 7,401 (8.9%) had experienced influenza and 270 (0.32%) underwent influenza-related hospitalization. Individuals who were vaccinated during the first season (n = 47,338) were older than non-vaccinated individuals (n = 35,808) (average age, 75.8 vs. 74.1 years, respectively). The multivariable analysis showed a lower incidence of influenza in vaccinated individuals (hazard ratio [HR], 0.47; 95% confidence interval [CI], 0.43-0.51; P < 0.001), while the incidence of hospitalization for influenza did not differ significantly by vaccination status (HR, 0.79; 95% CI, 0.53-1.18; P = 0.249). Protective effectiveness against incidence was maintained for 4 or 5 months after vaccination in those aged 65-69 and 80-years, 5 months in 70-79 years. CONCLUSIONS: Our study identified moderate vaccine effectiveness in preventing the incidence of influenza in the Japanese elderly. Vaccine effectiveness showed a trend of gradual attenuation. Clinicians should suspect influenza infection even in those vaccinated, especially in elderly individuals who had received vaccination more than 4 or 5 months previously.
引用
- Uemura K, Ono S, Michihata N, et al. Duration of influenza vaccine effectiveness in the elderly in Japan: A retrospective cohort study using large-scale population-based registry data. Vaccine. 2023. PMID: 37045684. doi:10.1016/j.vaccine.2023.03.066
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。